EVALUATION OF INTERFERONE-ALPHA TYPE 2A (ROFERON) ON PATIENTS WITH
CHRONIC HEPATITIS C

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALAVIAN S.M.; KABIR A.; HASHEMIAN A.; HASHEMI A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Razi Journal of Medical Sciences Year:621 | Volume: | Issue: Page(s): 0-0

Download Full-Text

View:

224

Download:

Cites:

Information Journal Paper

Title

EVALUATION OF INTERFERONE-ALPHA TYPE 2A (ROFERON) ON PATIENTS WITH CHRONIC HEPATITIS C

Author(s)

ALAVIAN S.M. | KABIR A. | HASHEMIAN A. | HASHEMI A. | Issue Writer Certificate

Keywords

1) INTERFERONE-ALPHA 2) ROFERON 3) HEPATITIS C

Abstract

Hepatitis C virus infection is affecting an estimated 200 million people worldwide and 210 thousand in Iran. It is a major cause of morbidity and mortality from liver disease. Interferon-alpha is the choice of treatment but interferone (IFN) with ribavirin is known more effective recently. This study evaluated effect of IFN on Iranian patients and predict response to therapy. This is a quasi experimental study on 33 patients of chronic hepatitis C that are treated by IFN-2a, 3 Mega units, three times in week for 12 months, subcutaneously. We assessed ALT, AST, alkaline phosphatase, total and direct billirubine at first, second week and every month till 12 months. HCV-RNA and biopsy were done at first and end of study. T test, chi2, ANOVA, correlation coefficient and regression models were used for analysis. %82.7 were ejucated under diploma. AST, ALT and alkaline phosphatase were decreased under normal range during treatment significantly(P=0.00005, P=0.0005 & P=0.001). Liver enzymes and billirubine normalized 2-4 months after treatment and the first biochemical break through was during first 6 months. %86.7 of all patients response to therapy biochemically. Percent of patients with negative HCV-RNA was more in the end of study significantly. (P<0.009) Mean biopsy score decreased significantly(P=0.03). Interferone-alpha decreases progression of liver disease, hepatocellular carcinoma, transplantation need and probably death. Total dose of IFN is more important than weekly dose or duration of therapy. Selection of patients with high probability response to therapy, instead of all of patients should be done. Biochemical response was high and quite acceptable. Significant models for prediction of the first time of response and the first biochemical break through during therapy are effective, cheap, easy and available. Results of this study suggest to give information about chronic hepatitis C to patients and doctors, too.

Cites

No record.

References

No record.

Cite

APA: Copy

ALAVIAN, S.M., KABIR, A., HASHEMIAN, A., & HASHEMI, A.. (2003). EVALUATION OF INTERFERONE-ALPHA TYPE 2A (ROFERON) ON PATIENTS WITH CHRONIC HEPATITIS C. RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES), 10(33), 0-0. SID. https://sid.ir/paper/530887/en

Vancouver: Copy

ALAVIAN S.M., KABIR A., HASHEMIAN A., HASHEMI A.. EVALUATION OF INTERFERONE-ALPHA TYPE 2A (ROFERON) ON PATIENTS WITH CHRONIC HEPATITIS C. RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES)[Internet]. 2003;10(33):0-0. Available from: https://sid.ir/paper/530887/en

IEEE: Copy

S.M. ALAVIAN, A. KABIR, A. HASHEMIAN, and A. HASHEMI, “EVALUATION OF INTERFERONE-ALPHA TYPE 2A (ROFERON) ON PATIENTS WITH CHRONIC HEPATITIS C,” RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES), vol. 10, no. 33, pp. 0–0, 2003, [Online]. Available: https://sid.ir/paper/530887/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops